FindTrial
Sign In

A Clinical Efficacy Observation Project, Open-Label, Multi-Center, Prospective, Non-Interventional Registry Study to Assess the Safety and Efficacy of PRP Technology in the Treatment of Knee Osteoarthritis

A Clinical Efficacy Observation Project, Open-Label, Multi-Center, Prospective, Non-Interventional Registry Study to Assess the Safety and Efficacy of PRP Technology in the Treatment of Knee Osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043850
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

case series:platelet-rich plasma, PRP

Sponsors

Department of Orthopedics, Qilu Hospital, Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or above. 2. Clinically confirmed patients with KOA.

Exclusion criteria

Exclusion criteria: 1. Patients with skin diseases around the injection site, skin ulceration around the joint puncture, or obvious joint swelling and effusion caused by other diseases cannot be excluded; 2. Dysfunction of coagulation, such as thrombocytopenia syndrome, severe thrombocytopenia; 3. Sepsis; 4. People with mental illness and unhealthy mental health.

Design outcomes

Primary

MeasureTime frame
Visual analog VAS score;—

Secondary

MeasureTime frame
Kellgren-Lawrence X-ray grading;WOMAC Arthrosis Function Score;Knee IKDC score;—

Countries

China

Contacts

Public ContactPeilai Liu
qlyygk2021@163.com+86 17316201595

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026